Skip to main content
43°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
The Latest Analyst Ratings For Ionis Pharmaceuticals
April 09, 2024
Tickers
IONS
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
March 13, 2024
Tickers
IONS
NEWS
Tags
General
IONS
Large Cap
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
February 22, 2024
Tickers
IONS
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Tickers
ACVA
ADI
AGI
AGR
Tags
VTLE
KW
VRSK
From
Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
February 01, 2024
Tickers
IONS
Tags
Market News
IONS
Benzinga
From
Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
News
Briefs
IONS
From
Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
January 22, 2024
Tickers
IONS
NEWS
Tags
Biotech
Equities
Market News
From
Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
January 18, 2024
Tickers
IONS
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Tickers
ALNY
ARM
CPRI
IONS
Tags
ALNY
Benzinga
IONS
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Tickers
ABBV
ALNY
CVS
GILD
Tags
ALNY
Benzinga
MRNA
From
Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
December 27, 2023
Tickers
IONS
TSM
UNH
Tags
NASDAQ:IONS,NYSE:UNH,NYSE:TSM
IONS
Market News
From
InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
Analyst Color
Trading Ideas
Market News
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
Market News
Biotech
Trading Ideas
From
Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
December 19, 2023
Tickers
IONS
TAK
Tags
Health Care
Contracts
Expert Ideas
From
Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
November 17, 2023
Tickers
IONS
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
November 02, 2023
Tickers
ARKG
ARKK
ARKQ
DKNG
Tags
ARKK
ARKQ
Equities
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
October 23, 2023
Tickers
IONS
Tags
IONS
Market News
Analyst Ratings
From
Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
October 17, 2023
Tickers
ARKG
ARKK
CRSP
EVS
Tags
CRSP
Elon Musk
EVs
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Tickers
ABBV
ADBE
ADSK
AKAM
Tags
IONS
BMBL
INTU
From
Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
RHHVF
Contracts
Health Care
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
September 27, 2023
Tickers
IONS
Tags
Market News
IONS
Benzinga
From
Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
September 26, 2023
Tickers
IONS
Tags
Movers
Benzinga
IONS
From
Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
September 26, 2023
Tickers
IONS
Tags
Benzinga
Movers
General
From
Benzinga
The 7 Most Hated Stocks by Institutional Traders
September 20, 2023
Tickers
GS
IONS
LLY
PDD
Tags
IONS
PDD
GS
From
InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
News
Briefs
IONS
From
Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Tickers
ACCD
ARKG
ARKK
ARKW
Tags
PACB
Cathie Wood
Markets
From
Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
July 31, 2023
Tickers
ALNY
AZN
IONS
Tags
Analyst Color
Trading Ideas
Price Target
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Tickers
A
ABR
ADBE
AIV
Tags
Intraday Update
Initiation
CPRI
From
Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
July 31, 2023
Tickers
AAPL
ADBE
BAX
CMCSA
Tags
PT Changes
Benzinga
ADBE
From
Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
Tickers
BIIB
IONS
NVS
Tags
Market News
Equities
Biotech
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.